Making Medicines Affordable

Home
About GBMA
Advocacy
Generics
Biosimilars
- GBMA Position on Biosimilars
- Key Figures on Biosimilars
Topics
News
- News 2020
- News 2019
- News 2018
- News 2017
- News 2016
- News 2015
- News 2014
GBMA Education
COVID-19 Virus
- COVID-19 Virus: The Facts

You are here: Home / COVID-19 Virus

COVID-19 Virus

Our Members

Juno

Sandoz logo

Mylan

Arrow logo

apotex

Celltrion Healthcare

Fresnius Kabi

generic_partners

southern_cross

commercial_eyes

sinapse

Generic Medicines: The Facts

Generic medicines are quality medicines at affordable prices. Ask your doctor to prescribe a generic medicine, or ask for a generic medicine next time you take your prescription to the pharmacy. … More…

The promise of Biosimilars

https://youtu.be/sBDur7xa084 Biosimilars provide a unique opportunity to help manage the growing costs of biological medicines on the PBS. They offer therapeutically equivalent and … More…

Budget 2020-21 – Australia’s ‘pandemic’ budget prioritises the needs of patients

October 7, 2020

6 October 2020 Canberra, ACT Generic and Biosimilar Medicines Association congratulates the Australian … More...

Australian patients must be able to access their medicines without undue delay

October 2, 2020

30 September 2020 Canberra, ACT The Generic and Biosimilar Medicines Association … More...

Australian patients to benefit from ongoing collaboration between peak medicine bodies

September 29, 2020

Canberra, ACT ACCC extends conditional authorisation to Medicines Australia and … More…